期刊文献+

布地奈德联合氨溴索雾化吸入治疗慢性阻塞性肺疾病急性加重期患者疗效观察 被引量:57

Observation on pulmicort repulse combined with ambroxol inhalation of foggy on the treatment of chronic obstructive pulmonary disease at acue exacerbation phase
下载PDF
导出
摘要 目的观察吸入用布地奈德混悬液联合氨溴索雾化吸入治疗慢性阻塞性肺疾病(COPD)急性加重期患者的疗效。方法对照组79例,给予持续低流量吸氧、抗感染、平喘及止咳化痰及维持水电解质酸碱平衡等常规治疗。治疗组82例患者,在常规治疗的基础上,加吸入用布地奈德混悬液联合氨溴索雾化吸入。观察疗效。结果对照组总有效率为82.27%,治疗组总有效率为93.90%,两组差异显著(P<0.01)。两组患者治疗前、治疗后的血气情况组内比较,有显著性差异,组间比较,无明显差异性。治疗组不良反应发生率明显低于对照组(P<0.05)。结论布地奈德联合氨溴索雾化吸入治疗COPD急性加重期患者疗效好,不良反应发生率低,值得临床推广使用。
机构地区 天津市胸科医院
出处 《中国生化药物杂志》 CAS CSCD 北大核心 2010年第2期133-134,共2页 Chinese Journal of Biochemical Pharmaceutics
  • 引文网络
  • 相关文献

参考文献3

二级参考文献16

  • 1Pauwels RA,Buist AS,Calverley PM,et al.Global strategy for the diagnosis,mangement,and prevention of chronic obstructive pulmonary disease.NHLBI/WHO Global Intiative for Chronic Obstructive Lung Disease(GOLD) Workshop summary[J].Am Respir Crit Care Med,2001,163:1256-1276.
  • 2Boyd G Morice AH,Pounsford JC,et al.An evaluation pf Salmeterol in the treatment of chronic obstructive pulmonary disease(COPD)[J].Eur Respir,1997,10(4):815-821.
  • 3Maltais F,Ostinelli J,Bourbeau J,et al.Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease:a randomized controlled trial[J].Am Respir Crit Care Med,2002,165:698-703.
  • 4Pauwels R A,Buist A S,Calverley P M,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease.NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary[J].Am J Respir Crit Care Med,2001,163(5):1256.
  • 5Renkema T E,Schouten J P,Koeter G H,et al.Effects of long-term treatment with corticosteroids in COPD[J].Chest,1996,109(5):1156.
  • 6Maltais F,Ostinelli J,Bourbeau J,et al.Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease:a randomized controlled trial[J].Am J Respir Crit Care Med,2002,165(5):698.
  • 7Oudijk E J,Lammers J W,Koenderman L.Systemic inflammation in chronic obstructive pulmonary disease[J].Eur Respir J,2003,46(11):5.
  • 8Niewoehner D E,Erbland M L,Deupree R H,et al.Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease[J].N Engl J Med,1999,340(25):1941.
  • 9Davies L,Angus R M,Calverley P M A.Oral corticosteroids in patients admitted to hospital with exacerbations of chronic obstructive pulmonary disease:a prospective randomized controlled trial[J].Lancet,1999,354(9177):456.
  • 10Osman L M,Godden D J,Friend J A R,et al.Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease[J].Thorax,1999,52(1):67.

共引文献1092

同被引文献333

引证文献57

二级引证文献408

;
使用帮助 返回顶部